China Resources Pharmaceutical Group Limited (FRA:640)

FRA:640 Statistics

Total Valuation

FRA:640 has a market cap or net worth of EUR 3.31 billion. The enterprise value is 16.94 billion.

Market Cap	3.31B
Enterprise Value	16.94B

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	Sep 11, 2025

Share Statistics

Current Share Class	6.28B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.83B

Valuation Ratios

The trailing PE ratio is 9.95 and the forward PE ratio is 7.14.

PE Ratio	9.95
Forward PE	7.14
PS Ratio	0.11
PB Ratio	0.25
P/TBV Ratio	1.90
P/FCF Ratio	1.62
P/OCF Ratio	1.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.01, with an EV/FCF ratio of 8.28.

EV / Earnings	50.91
EV / Sales	0.54
EV / EBITDA	9.01
EV / EBIT	11.72
EV / FCF	8.28

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.74.

Current Ratio	1.41
Quick Ratio	1.05
Debt / Equity	0.74
Debt / EBITDA	5.40
Debt / FCF	4.82
Interest Coverage	5.63

Financial Efficiency

Return on equity (ROE) is 7.57% and return on invested capital (ROIC) is 3.99%.

Return on Equity (ROE)	7.57%
Return on Assets (ROA)	2.66%
Return on Invested Capital (ROIC)	3.99%
Return on Capital Employed (ROCE)	8.25%
Revenue Per Employee	360,651
Profits Per Employee	3,870
Employee Count	72,700
Asset Turnover	0.94
Inventory Turnover	5.57

Taxes

In the past 12 months, FRA:640 has paid 283.30 million in taxes.

Income Tax	283.30M
Effective Tax Rate	23.14%

Stock Price Statistics

The stock price has decreased by -19.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.05%
50-Day Moving Average	0.55
200-Day Moving Average	0.58
Relative Strength Index (RSI)	39.74
Average Volume (20 Days)	278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:640 had revenue of EUR 31.02 billion and earned 332.79 million in profits. Earnings per share was 0.05.

Revenue	31.02B
Gross Profit	4.90B
Operating Income	1.40B
Pretax Income	1.22B
Net Income	332.79M
EBITDA	1.74B
EBIT	1.40B
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 3.75 billion in cash and 9.87 billion in debt, giving a net cash position of -6.12 billion.

Cash & Cash Equivalents	3.75B
Total Debt	9.87B
Net Cash	-6.12B
Net Cash Per Share	n/a
Equity (Book Value)	13.32B
Book Value Per Share	0.95
Working Capital	6.98B

Cash Flow

In the last 12 months, operating cash flow was 2.39 billion and capital expenditures -341.88 million, giving a free cash flow of 2.05 billion.

Operating Cash Flow	2.39B
Capital Expenditures	-341.88M
Free Cash Flow	2.05B
FCF Per Share	n/a

Margins

Gross margin is 15.81%, with operating and profit margins of 4.51% and 1.08%.

Gross Margin	15.81%
Operating Margin	4.51%
Pretax Margin	3.95%
Profit Margin	1.08%
EBITDA Margin	5.60%
EBIT Margin	4.51%
FCF Margin	6.60%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 2.93%.

Dividend Per Share	0.01
Dividend Yield	2.93%
Dividend Growth (YoY)	-50.98%
Years of Dividend Growth	3
Payout Ratio	52.74%
Buyback Yield	n/a
Shareholder Yield	2.93%
Earnings Yield	10.05%
FCF Yield	61.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:640 has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	6